| ADTX 0.0127 -2.31% | SOXS 4.72 -5.03% | SPCX 160.95 19.22% | DFNS 0.233 -9.20% | BITO 8.65 0.12% | RUBI 0.4676 -24.62% | TZA 4.16 -2.58% | CAST 1.55 140.68% | AAL 14.98 2.25% | INTC 124.57 6.51% | SPCE 3.91 -31.76% | SHFS 0.276 16.46% | SRXH 0.148 17.65% | NOK 14.795 5.00% | NVDA 205.19 0.16% | BYAH 1.47 40.00% | SPDN 8.81 -0.45% | TQQQ 77.52 1.99% | TSLL 13.59 3.58% | PAVS 0.208 -28.28% | CPOP 0.195 -81.43% | SMCI 30.46 -4.72% | CUPR 3.97 64.73% | VSME 1.69 52.25% | YYGH 0.119 -3.25% | SQQQ 40.04 -1.93% | RKLB 102.39 -10.79% | TSLA 406.43 1.82% | NVD 5.02 -0.40% | WOK 0.0753 -17.70% | SPY 741.75 0.54% | ASTS 82.41 -15.53% | KEEL 5.59 1.27% | ONDS 9.33 -5.09% | SPYM 87.06 0.25% | AMZN 238.55 -1.23% | XLF 53.34 1.37% | SATS 114.08 -10.97% | QQQ 721.34 0.59% | SOFI 16.58 -0.54% | PLUG 2.76 -2.47% | SOXL 234.68 4.77% | GRAB 3.3 -1.49% | DRIP 4.74 -2.47% | AMC 2.34 2.63% | IREN 59.77 5.40% | HKIT 0.5025 -10.11% | RKLZ 3.01 21.37% | RZLV 2.68 5.93% | MARA 14.08 3.45%

Community Health Systems, Inc. (NYSE: CYH) Surpasses Earnings Estimates

Community Health Systems, Inc. (NYSE:CYH) is a prominent player in the healthcare sector, specifically within the Zacks Medical - Hospital industry. The company operates a network of hospitals and healthcare facilities across the United States, providing a range of medical services. CYH competes with other healthcare providers in delivering quality care and maintaining financial stability.

On February 18, 2026, CYH reported its earnings, showcasing an impressive earnings per share (EPS) of $0.80, which significantly exceeded the estimated EPS of -$0.20, reflecting a substantial improvement from the previous year's loss of $0.42 per share. The company has consistently surpassed consensus earnings estimates in three of the last four quarters.

Despite reporting a revenue of approximately $3.106 billion, which was slightly below the estimated $3.137 billion, CYH's financial performance remains noteworthy. The revenue for the quarter ending December 2025 fell short of the Zacks Consensus Estimate by 1.18%, yet the company has exceeded consensus revenue estimates three times in the last four quarters. This indicates a strong track record of financial performance.

CYH's financial health is further demonstrated by its net income attributable to stockholders, which reached $110 million, translating to $0.81 per diluted share. This marks a significant turnaround from the previous period's net loss of $70 million. The company's price-to-earnings (P/E) ratio of approximately 0.88 and price-to-sales ratio of about 0.037 suggest a relatively low valuation compared to its earnings and sales.

The company's liquidity position is solid, with a current ratio of about 1.46, indicating its ability to cover short-term obligations. However, the debt-to-equity ratio is negative at approximately -0.79, showing more liabilities than equity. Despite this, CYH's enterprise value to sales ratio of around 0.069 and enterprise value to operating cash flow ratio of approximately 1.59 reflect a reasonable valuation in relation to its sales and cash flow.

Published on: February 19, 2026